Overview

• The treaty establishes mechanisms for rapid pathogen data sharing and equitable access to vaccines and medical supplies to address disparities seen during COVID-19.
• It mandates pharmaceutical companies to donate 10% of their production for distribution in low-income countries, though specific implementation details are still under discussion.
• The agreement emphasizes strengthening national healthcare systems and pandemic surveillance to prevent future health crises.
• Notably, the United States and Argentina are not participating, highlighting geopolitical divides within global health governance.
• The treaty will require ratification by at least 60 countries to take effect, a process expected to span several years.